Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs have?
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs has 718 citations in the OpenAlex counts ScholarIQ stores.
When was Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs published?
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs has 2020 year in the ScholarIQ index.
What is the open-access status of Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs?
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs has green oa status in the ScholarIQ index.
What is the DOI of Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs?
The DOI for Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs is on the source record.
What is the PMID of Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs?
The PMID for Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs is on the source record.
What is the OpenAlex record for Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs?
The OpenAlex for Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs is on the source record.